Supercharging immune cells to battle blood cancer: Breakthrough in cancer immunotherapy
A new study reveals a groundbreaking approach to immunotherapy, demonstrating that blocking the interaction between the CD300A receptor and phosphatidylserine...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
A new study reveals a groundbreaking approach to immunotherapy, demonstrating that blocking the interaction between the CD300A receptor and phosphatidylserine...
SINGAPORE – A groundbreaking international study led by Dr Li Qi-Jing from the Agency for Science, Technology and Research (A*STAR)...
(WASHINGTON, May 9, 2024) – Standard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults...
Wilms tumor is the most common renal malignancy in children. miR-146a, a highly conserved small noncoding RNA, plays a critical...
BETHESDA, MD. (May 9, 2024) — Colorectal cancer incidence has steadily increased among younger people in the U.S. over the...
BETHESDA, MD. (May 9, 2024) — A simple oral rinse could provide early detection of gastric cancer, the fourth-leading cause...
Lugano, Switzerland, 8 May 2024 – ESMO Breast Cancer 2024 will be held in Berlin, Germany, between 15-17 May where...
May 8, 2024—(BRONX, NY)—Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough...
Study led by researchers at Brigham and Women’s Hospital found an association between appendix removal and a decreased risk of...
Another ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) treatment trial is open as part of the ComboMATCH precision medicine study platform. ComboMATCH-E5...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine